Acebutolol
Ambenonium may increase the bradycardic activities of Acebutolol.
Acetylcholine
The risk or severity of adverse effects can be increased when Ambenonium is combined with Acetylcholine.
Acetylcholine Chloride
The risk or severity of adverse effects can be increased when Ambenonium is combined with Acetylcholine.
Advertisement
Aclidinium
The therapeutic efficacy of Aclidinium can be decreased when used in combination with Ambenonium.
Alclometasone
The risk or severity of adverse effects can be increased when Alclometasone is combined with Ambenonium.
Aldosterone
The risk or severity of adverse effects can be increased when Aldosterone is combined with Ambenonium.
Advertisement
Alprenolol
Ambenonium may increase the bradycardic activities of Alprenolol.
Amcinonide
The risk or severity of adverse effects can be increased when Amcinonide is combined with Ambenonium.
Androstenedione
The risk or severity of adverse effects can be increased when Androstenedione is combined with Ambenonium.
Advertisement
Atenolol
Ambenonium may increase the bradycardic activities of Atenolol.
Atracurium
The therapeutic efficacy of Atracurium can be decreased when used in combination with Ambenonium.
Atracurium Besylate
The therapeutic efficacy of Atracurium besylate can be decreased when used in combination with Ambenonium.
Atropine
The therapeutic efficacy of Atropine can be decreased when used in combination with Ambenonium.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Ambenonium.
Benactyzine
The therapeutic efficacy of Benactyzine can be decreased when used in combination with Ambenonium.
Benztropine
The therapeutic efficacy of Benzatropine can be decreased when used in combination with Ambenonium.
Betamethasone
The risk or severity of adverse effects can be increased when Betamethasone is combined with Ambenonium.
Betaxolol
Ambenonium may increase the bradycardic activities of Betaxolol.
Bethanechol
The risk or severity of adverse effects can be increased when Ambenonium is combined with Bethanechol.
Biperiden
The therapeutic efficacy of Biperiden can be decreased when used in combination with Ambenonium.
Bisoprolol
Ambenonium may increase the bradycardic activities of Bisoprolol.
Bopindolol
Ambenonium may increase the bradycardic activities of Bopindolol.
Budesonide
The risk or severity of adverse effects can be increased when Budesonide is combined with Ambenonium.
Bupranolol
Ambenonium may increase the bradycardic activities of Bupranolol.
Butylscopolamine
The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Ambenonium.
Carbachol
The risk or severity of adverse effects can be increased when Ambenonium is combined with Carbachol.
Carteolol
Ambenonium may increase the bradycardic activities of Carteolol.
Carvedilol
Ambenonium may increase the bradycardic activities of Carvedilol.
Celiprolol
Ambenonium may increase the bradycardic activities of Celiprolol.
Cevimeline
The risk or severity of adverse effects can be increased when Ambenonium is combined with Cevimeline.
Chlorphenoxamine
The therapeutic efficacy of Chlorphenoxamine can be decreased when used in combination with Ambenonium.
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Ambenonium.
Clobetasol
The risk or severity of adverse effects can be increased when Clobetasol is combined with Ambenonium.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Ambenonium.
Clobetasone
The risk or severity of adverse effects can be increased when Clobetasone is combined with Ambenonium.
Clocortolone
The risk or severity of adverse effects can be increased when Clocortolone is combined with Ambenonium.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Ambenonium.
Cyclopentolate
The therapeutic efficacy of Cyclopentolate can be decreased when used in combination with Ambenonium.
Darifenacin
The therapeutic efficacy of Darifenacin can be decreased when used in combination with Ambenonium.
Deflazacort
The risk or severity of adverse effects can be increased when Deflazacort is combined with Ambenonium.
Desloratadine
The therapeutic efficacy of Desloratadine can be decreased when used in combination with Ambenonium.
Desonide
The risk or severity of adverse effects can be increased when Desonide is combined with Ambenonium.
Desoximetasone
The risk or severity of adverse effects can be increased when Desoximetasone is combined with Ambenonium.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Desoxycorticosterone acetate is combined with Ambenonium.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Desoxycorticosterone Pivalate is combined with Ambenonium.
Dexamethasone
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ambenonium.
Dexetimide
The therapeutic efficacy of Dexetimide can be decreased when used in combination with Ambenonium.
Dicyclomine
The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Ambenonium.
Diflorasone
The risk or severity of adverse effects can be increased when Diflorasone is combined with Ambenonium.
Diflucortolone
The risk or severity of adverse effects can be increased when Difluocortolone is combined with Ambenonium.
Difluprednate
The risk or severity of adverse effects can be increased when Difluprednate is combined with Ambenonium.
Dipyridamole
The therapeutic efficacy of Ambenonium can be decreased when used in combination with Dipyridamole.
Esmolol
Ambenonium may increase the bradycardic activities of Esmolol.
Estrone
The risk or severity of adverse effects can be increased when Estrone is combined with Ambenonium.
Fesoterodine
The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Ambenonium.
Fludrocortisone
The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Ambenonium.
Flumethasone
The risk or severity of adverse effects can be increased when Flumethasone is combined with Ambenonium.
Flunisolide
The risk or severity of adverse effects can be increased when Flunisolide is combined with Ambenonium.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Flunisolide is combined with Ambenonium.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Ambenonium.
Fluocinonide
The risk or severity of adverse effects can be increased when Fluocinonide is combined with Ambenonium.
Fluocortolone
The risk or severity of adverse effects can be increased when Fluocortolone is combined with Ambenonium.
Fluorometholone
The risk or severity of adverse effects can be increased when Fluorometholone is combined with Ambenonium.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Fluprednidene is combined with Ambenonium.
Fluprednisolone
The risk or severity of adverse effects can be increased when Fluprednisolone is combined with Ambenonium.
Flurandrenolide
The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Ambenonium.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Ambenonium.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ambenonium.
Formestane
The risk or severity of adverse effects can be increased when Formestane is combined with Ambenonium.
Gallamine Triethiodide
The therapeutic efficacy of Gallamine Triethiodide can be decreased when used in combination with Ambenonium.
Glycopyrronium
The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ambenonium.
Halcinonide
The risk or severity of adverse effects can be increased when Halcinonide is combined with Ambenonium.
Halobetasol
The risk or severity of adverse effects can be increased when Ulobetasol is combined with Ambenonium.
Homatropine
The therapeutic efficacy of Homatropine can be decreased when used in combination with Ambenonium.
Hydrocortisone
The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Ambenonium.
Hyoscyamine
The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Ambenonium.
Ipratropium Bromide
The therapeutic efficacy of Ipratropium bromide can be decreased when used in combination with Ambenonium.
Ipratropium Bromide Anhydrous
The therapeutic efficacy of Ipratropium bromide can be decreased when used in combination with Ambenonium.
Labetalol
Ambenonium may increase the bradycardic activities of Labetalol.
Levobunolol
Ambenonium may increase the bradycardic activities of Levobunolol.
Lobeline
The risk or severity of adverse effects can be increased when Ambenonium is combined with Lobeline.
Loteprednol
The risk or severity of adverse effects can be increased when Loteprednol is combined with Ambenonium.
Mecamylamine
The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Ambenonium.
Medrysone
The risk or severity of adverse effects can be increased when Medrysone is combined with Ambenonium.
Methacholine
The risk or severity of adverse effects can be increased when Ambenonium is combined with Methacholine.
Methantheline
The therapeutic efficacy of Methantheline can be decreased when used in combination with Ambenonium.
Methixene
The therapeutic efficacy of Metixene can be decreased when used in combination with Ambenonium.
Methscopolamine
The therapeutic efficacy of Methscopolamine can be decreased when used in combination with Ambenonium.
Methscopolamine Bromide
The therapeutic efficacy of Methylscopolamine bromide can be decreased when used in combination with Ambenonium.
Methylprednisolone
The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Ambenonium.
Metipranolol
Ambenonium may increase the bradycardic activities of Metipranolol.
Metoprolol
Ambenonium may increase the bradycardic activities of Metoprolol.
Mivacurium
Ambenonium may decrease the neuromuscular blocking activities of Mivacurium.
Mometasone
The risk or severity of adverse effects can be increased when Mometasone is combined with Ambenonium.
Nadolol
Ambenonium may increase the bradycardic activities of Nadolol.
Nebivolol
Ambenonium may increase the bradycardic activities of Nebivolol.
Nicotine
The risk or severity of adverse effects can be increased when Ambenonium is combined with Nicotine.
Nicotine Polacrilex
The risk or severity of adverse effects can be increased when Ambenonium is combined with Nicotine.
Octotropine Methylbromide
The therapeutic efficacy of Anisotropine Methylbromide can be decreased when used in combination with Ambenonium.
Octylonium
The therapeutic efficacy of Otilonium can be decreased when used in combination with Ambenonium.
Orphenadrine
The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Ambenonium.
Oxitropium
The therapeutic efficacy of Oxitropium can be decreased when used in combination with Ambenonium.
Oxprenolol
Ambenonium may increase the bradycardic activities of Oxprenolol.
Oxybutynin
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Ambenonium.
Oxyphenonium
The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Ambenonium.
Pancuronium
The therapeutic efficacy of Pancuronium can be decreased when used in combination with Ambenonium.
Pancuronium Bromide
The therapeutic efficacy of Pancuronium can be decreased when used in combination with Ambenonium.
Paramethasone
The risk or severity of adverse effects can be increased when Paramethasone is combined with Ambenonium.
Penbutolol
Ambenonium may increase the bradycardic activities of Penbutolol.
Pilocarpine
The risk or severity of adverse effects can be increased when Ambenonium is combined with Pilocarpine.
Pindolol
Ambenonium may increase the bradycardic activities of Pindolol.
Pipecuronium
The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Ambenonium.
Pirenzepine
The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Ambenonium.
Practolol
Ambenonium may increase the bradycardic activities of Practolol.
Prasterone
The risk or severity of adverse effects can be increased when Prasterone is combined with Ambenonium.
Prednicarbate
The risk or severity of adverse effects can be increased when Prednicarbate is combined with Ambenonium.
Prednisolone
The risk or severity of adverse effects can be increased when Prednisolone is combined with Ambenonium.
Prednisone
The risk or severity of adverse effects can be increased when Prednisone is combined with Ambenonium.
Pregnenolone
The risk or severity of adverse effects can be increased when Pregnenolone is combined with Ambenonium.
Procyclidine
The therapeutic efficacy of Procyclidine can be decreased when used in combination with Ambenonium.
Profenamine
The therapeutic efficacy of Ethopropazine can be decreased when used in combination with Ambenonium.
Propantheline
The therapeutic efficacy of Propantheline can be decreased when used in combination with Ambenonium.
Propantheline Bromide
The therapeutic efficacy of Propantheline can be decreased when used in combination with Ambenonium.
Propiverine
The therapeutic efficacy of Propiverine can be decreased when used in combination with Ambenonium.
Propranolol
Ambenonium may increase the bradycardic activities of Propranolol.
Quinidine
The therapeutic efficacy of Quinidine can be decreased when used in combination with Ambenonium.
Rapacuronium
Ambenonium may decrease the neuromuscular blocking activities of Rapacuronium.
Rimexolone
The risk or severity of adverse effects can be increased when Rimexolone is combined with Ambenonium.
Scopolamine
The therapeutic efficacy of Scopolamine can be decreased when used in combination with Ambenonium.
Scopolamine Hydrobromide
The therapeutic efficacy of Scopolamine can be decreased when used in combination with Ambenonium.
Solifenacin
The therapeutic efficacy of Solifenacin can be decreased when used in combination with Ambenonium.
Sotalol
Ambenonium may increase the bradycardic activities of Sotalol.
Succinylcholine
The serum concentration of Succinylcholine can be increased when it is combined with Ambenonium.
Talinolol
Ambenonium may increase the bradycardic activities of Talinolol.
Timolol
Ambenonium may increase the bradycardic activities of Timolol.
Timolol Anhydrous
Ambenonium may increase the bradycardic activities of Timolol.
Tiotropium
The therapeutic efficacy of Tiotropium can be decreased when used in combination with Ambenonium.
Tixocortol
The risk or severity of adverse effects can be increased when Tixocortol is combined with Ambenonium.
Tolterodine
The therapeutic efficacy of Tolterodine can be decreased when used in combination with Ambenonium.
Triamcinolone
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Ambenonium.
Trihexyphenidyl
The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Ambenonium.
Trihexyphenidyl Hydrochloride
The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Ambenonium.
Trimethaphan
The therapeutic efficacy of Trimethaphan can be decreased when used in combination with Ambenonium.
Tropicamide
The therapeutic efficacy of Tropicamide can be decreased when used in combination with Ambenonium.
Trospium
The therapeutic efficacy of Trospium can be decreased when used in combination with Ambenonium.
Tubocurarine
The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Ambenonium.
Umeclidinium
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Ambenonium.
Varenicline
The risk or severity of adverse effects can be increased when Ambenonium is combined with Varenicline.
Vecuronium
The therapeutic efficacy of Vecuronium can be decreased when used in combination with Ambenonium.
